| Cascade Health Solutions 2650 Suzanne Way Suite 200, Eugene, OR, 97408 | |
| (541) 228-3050 |
News Archive
Agfa HealthCare announced today that Massachusetts General Hospital (MGH), a teaching hospital affiliated with Harvard Medical School located in Boston Mass., installed several of Agfa HealthCare's direct radiography (DR) technologies to update their inpatient and outpatient facilities. The eight DX-D 100 mobile DR systems and eight DX-D 600 fully automated DR rooms replace previous technologies.
A new study, conducted by Ellen Kurtzman, R.N., M.P.H., FAAN, assistant research professor in the GW School of Nursing, and colleagues, published in the April 2011 issue of Health Affairs, highlights the importance of transitional care in reaching the goals of health reform, and provides evidence-based strategies to guide its implementation.
Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.
Mindfulness has been shown to reduce negative emotions in both healthy individuals as well as patients with psychological problems. Studies have also shown that mindfulness is effective for treating clinical emotional problems like anxiety, depression, stress and trauma related disorders.
› Verified 1 days ago
| Name | Cascade Health Solutions |
|---|---|
| Location | 2650 Suzanne Way Suite 200, Eugene, Oregon |
| Hospice ID | 381501 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| SSA county code | 190 |
News Archive
Agfa HealthCare announced today that Massachusetts General Hospital (MGH), a teaching hospital affiliated with Harvard Medical School located in Boston Mass., installed several of Agfa HealthCare's direct radiography (DR) technologies to update their inpatient and outpatient facilities. The eight DX-D 100 mobile DR systems and eight DX-D 600 fully automated DR rooms replace previous technologies.
A new study, conducted by Ellen Kurtzman, R.N., M.P.H., FAAN, assistant research professor in the GW School of Nursing, and colleagues, published in the April 2011 issue of Health Affairs, highlights the importance of transitional care in reaching the goals of health reform, and provides evidence-based strategies to guide its implementation.
Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.
Mindfulness has been shown to reduce negative emotions in both healthy individuals as well as patients with psychological problems. Studies have also shown that mindfulness is effective for treating clinical emotional problems like anxiety, depression, stress and trauma related disorders.
› Verified 1 days ago
| NPI Number | 1093753386 |
| Organization Name | Willamette Community Health Solutions |
| Address | 2650 Suzanne Way, #200 Eugene, Oregon, 97408 |
| Phone Number | (541)228-3008 |
News Archive
Agfa HealthCare announced today that Massachusetts General Hospital (MGH), a teaching hospital affiliated with Harvard Medical School located in Boston Mass., installed several of Agfa HealthCare's direct radiography (DR) technologies to update their inpatient and outpatient facilities. The eight DX-D 100 mobile DR systems and eight DX-D 600 fully automated DR rooms replace previous technologies.
A new study, conducted by Ellen Kurtzman, R.N., M.P.H., FAAN, assistant research professor in the GW School of Nursing, and colleagues, published in the April 2011 issue of Health Affairs, highlights the importance of transitional care in reaching the goals of health reform, and provides evidence-based strategies to guide its implementation.
Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.
Mindfulness has been shown to reduce negative emotions in both healthy individuals as well as patients with psychological problems. Studies have also shown that mindfulness is effective for treating clinical emotional problems like anxiety, depression, stress and trauma related disorders.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 96.8 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 72.7 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 97.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 99.4 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Agfa HealthCare announced today that Massachusetts General Hospital (MGH), a teaching hospital affiliated with Harvard Medical School located in Boston Mass., installed several of Agfa HealthCare's direct radiography (DR) technologies to update their inpatient and outpatient facilities. The eight DX-D 100 mobile DR systems and eight DX-D 600 fully automated DR rooms replace previous technologies.
A new study, conducted by Ellen Kurtzman, R.N., M.P.H., FAAN, assistant research professor in the GW School of Nursing, and colleagues, published in the April 2011 issue of Health Affairs, highlights the importance of transitional care in reaching the goals of health reform, and provides evidence-based strategies to guide its implementation.
Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.
Mindfulness has been shown to reduce negative emotions in both healthy individuals as well as patients with psychological problems. Studies have also shown that mindfulness is effective for treating clinical emotional problems like anxiety, depression, stress and trauma related disorders.
› Verified 1 days ago
| Home Health Aides | 11 |
| Counselors | 2 |
| Homemakers | 11 |
| Medical Social Workers | 6 |
| Physicians | 4 |
| Registered Nurses | 30 |
| Total Employees | 64 |
|---|
News Archive
Agfa HealthCare announced today that Massachusetts General Hospital (MGH), a teaching hospital affiliated with Harvard Medical School located in Boston Mass., installed several of Agfa HealthCare's direct radiography (DR) technologies to update their inpatient and outpatient facilities. The eight DX-D 100 mobile DR systems and eight DX-D 600 fully automated DR rooms replace previous technologies.
A new study, conducted by Ellen Kurtzman, R.N., M.P.H., FAAN, assistant research professor in the GW School of Nursing, and colleagues, published in the April 2011 issue of Health Affairs, highlights the importance of transitional care in reaching the goals of health reform, and provides evidence-based strategies to guide its implementation.
Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.
Mindfulness has been shown to reduce negative emotions in both healthy individuals as well as patients with psychological problems. Studies have also shown that mindfulness is effective for treating clinical emotional problems like anxiety, depression, stress and trauma related disorders.
› Verified 1 days ago
| Others | 91 |
| Total Volunteers | 91 |
|---|
News Archive
Agfa HealthCare announced today that Massachusetts General Hospital (MGH), a teaching hospital affiliated with Harvard Medical School located in Boston Mass., installed several of Agfa HealthCare's direct radiography (DR) technologies to update their inpatient and outpatient facilities. The eight DX-D 100 mobile DR systems and eight DX-D 600 fully automated DR rooms replace previous technologies.
A new study, conducted by Ellen Kurtzman, R.N., M.P.H., FAAN, assistant research professor in the GW School of Nursing, and colleagues, published in the April 2011 issue of Health Affairs, highlights the importance of transitional care in reaching the goals of health reform, and provides evidence-based strategies to guide its implementation.
Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.
Mindfulness has been shown to reduce negative emotions in both healthy individuals as well as patients with psychological problems. Studies have also shown that mindfulness is effective for treating clinical emotional problems like anxiety, depression, stress and trauma related disorders.
› Verified 1 days ago
| Sacred Heart Hospice Location: 677 E 12th Ave, Suite N110, Eugene, Oregon, 97401 Phone: (541) 228-3050 |
| Cascade Health Solutions Location: 2650 Suzanne Way Suite 200, Eugene, Oregon, 97408 Phone: (541) 228-3050 |